Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH

J Thromb Haemost. 2015 Nov;13(11):2119-26. doi: 10.1111/jth.13140.
No abstract available

Publication types

  • Consensus Development Conference

MeSH terms

  • Antithrombins / adverse effects*
  • Antithrombins / therapeutic use
  • Atrial Fibrillation / blood
  • Atrial Fibrillation / complications*
  • Clinical Trials, Phase III as Topic
  • Factor Xa Inhibitors / adverse effects*
  • Factor Xa Inhibitors / therapeutic use
  • Hemorrhage / chemically induced*
  • Hemorrhage / diagnosis
  • Hospitalization
  • Humans
  • Patient Acceptance of Health Care
  • Quality of Life
  • Severity of Illness Index
  • Thrombophilia / drug therapy*
  • Thrombophilia / etiology
  • Venous Thromboembolism / drug therapy*

Substances

  • Antithrombins
  • Factor Xa Inhibitors